Takehiro Nakahara, Raita Miyazawa, Yu Iwabuchi, Kai Tonda, Nupoor Narula, H William Strauss, Jagat Narula, Masahiro Jinzaki
{"title":"主动脉对 18F-NaF 和 18F-FDG 的摄取及钙化可预测腹主动脉瘤的发展,并可通过药物治疗减弱。","authors":"Takehiro Nakahara, Raita Miyazawa, Yu Iwabuchi, Kai Tonda, Nupoor Narula, H William Strauss, Jagat Narula, Masahiro Jinzaki","doi":"10.1161/ATVBAHA.124.321110","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Abdominal aortic aneurysms expand over time and increase the risk of fatal ruptures. To predict expansion, the isolated assessment of <sup>18</sup>F-fluorodeoxyglucose (FDG) and sodium fluoride (NaF) uptake or calcification volume in aneurysms has been investigated with variability in results. We systematically evaluated whether <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake was predictive of abdominal aortic aneurysm expansion.</p><p><strong>Methods: </strong>Seventy-four male Sprague-Dawley rat abdominal aortic aneurysm models were imaged using positron emission tomography-computed tomography with <sup>18</sup>F-FDG and <sup>18</sup>F-NaF at 1, 2, 4, 6, and 8 weeks after CaCl<sub>2</sub> or saline stimulation. In the 1-week cohort (n=25), the correlation between <sup>18</sup>F-FDG or <sup>18</sup>F-NaF uptake and pathological markers was investigated. In the time course cohort (n=49), animals received either atorvastatin, losartan, aldactone, or risedronate to assess the effect of these drugs, and the relationship between aortic size and sequential <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake or calcification volume was examined.</p><p><strong>Results: </strong>In the 1-week cohort, the maximum standard unit value of <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake correlated with CD68- (r=0.82; <i>P</i>=0.001) and von Kossa staining-positive areas (r=0.89; <i>P</i><0.001), respectively. In the time course cohort, <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake changed in a time-dependent manner and drugs attenuated this uptake. Specifically, <sup>18</sup>F-FDG showed high uptake at weeks 1 and 2, whereas a high <sup>18</sup>F-NaF uptake was noted throughout the study period. Atorvastatin and risedronate showed a decreased and increased aortic size, respectively. The final aortic area correlated well with <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake and calcification volume, especially at 1 and 2 weeks (<sup>18</sup>F-NaF [1 week]: r=0.61, <sup>18</sup>F-FDG [2 weeks]: r=0.51, calcification volume [1 week]: r=0.59; <i>P</i><0.001). Multiple linear regression analysis showed that the combination of these factors predicted the final aortic size, with <sup>18</sup>F-NaF uptake at 1 week being the strongest predictor.</p><p><strong>Conclusions: </strong>The uptake of <sup>18</sup>F-NaF and <sup>18</sup>F-FDG and the calcification volume at appropriate times correlated with the development of abdominal aortic aneurysms, with <sup>18</sup>F-NaF uptake being the strongest predictor.</p>","PeriodicalId":8401,"journal":{"name":"Arteriosclerosis, Thrombosis, and Vascular Biology","volume":null,"pages":null},"PeriodicalIF":7.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Aortic Uptake of <sup>18</sup>F-NaF and <sup>18</sup>F-FDG and Calcification Predict the Development of Abdominal Aortic Aneurysms and Is Attenuated by Drug Therapy.\",\"authors\":\"Takehiro Nakahara, Raita Miyazawa, Yu Iwabuchi, Kai Tonda, Nupoor Narula, H William Strauss, Jagat Narula, Masahiro Jinzaki\",\"doi\":\"10.1161/ATVBAHA.124.321110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Abdominal aortic aneurysms expand over time and increase the risk of fatal ruptures. To predict expansion, the isolated assessment of <sup>18</sup>F-fluorodeoxyglucose (FDG) and sodium fluoride (NaF) uptake or calcification volume in aneurysms has been investigated with variability in results. We systematically evaluated whether <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake was predictive of abdominal aortic aneurysm expansion.</p><p><strong>Methods: </strong>Seventy-four male Sprague-Dawley rat abdominal aortic aneurysm models were imaged using positron emission tomography-computed tomography with <sup>18</sup>F-FDG and <sup>18</sup>F-NaF at 1, 2, 4, 6, and 8 weeks after CaCl<sub>2</sub> or saline stimulation. In the 1-week cohort (n=25), the correlation between <sup>18</sup>F-FDG or <sup>18</sup>F-NaF uptake and pathological markers was investigated. In the time course cohort (n=49), animals received either atorvastatin, losartan, aldactone, or risedronate to assess the effect of these drugs, and the relationship between aortic size and sequential <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake or calcification volume was examined.</p><p><strong>Results: </strong>In the 1-week cohort, the maximum standard unit value of <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake correlated with CD68- (r=0.82; <i>P</i>=0.001) and von Kossa staining-positive areas (r=0.89; <i>P</i><0.001), respectively. In the time course cohort, <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake changed in a time-dependent manner and drugs attenuated this uptake. Specifically, <sup>18</sup>F-FDG showed high uptake at weeks 1 and 2, whereas a high <sup>18</sup>F-NaF uptake was noted throughout the study period. Atorvastatin and risedronate showed a decreased and increased aortic size, respectively. The final aortic area correlated well with <sup>18</sup>F-FDG and <sup>18</sup>F-NaF uptake and calcification volume, especially at 1 and 2 weeks (<sup>18</sup>F-NaF [1 week]: r=0.61, <sup>18</sup>F-FDG [2 weeks]: r=0.51, calcification volume [1 week]: r=0.59; <i>P</i><0.001). Multiple linear regression analysis showed that the combination of these factors predicted the final aortic size, with <sup>18</sup>F-NaF uptake at 1 week being the strongest predictor.</p><p><strong>Conclusions: </strong>The uptake of <sup>18</sup>F-NaF and <sup>18</sup>F-FDG and the calcification volume at appropriate times correlated with the development of abdominal aortic aneurysms, with <sup>18</sup>F-NaF uptake being the strongest predictor.</p>\",\"PeriodicalId\":8401,\"journal\":{\"name\":\"Arteriosclerosis, Thrombosis, and Vascular Biology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Arteriosclerosis, Thrombosis, and Vascular Biology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1161/ATVBAHA.124.321110\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arteriosclerosis, Thrombosis, and Vascular Biology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/ATVBAHA.124.321110","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Aortic Uptake of 18F-NaF and 18F-FDG and Calcification Predict the Development of Abdominal Aortic Aneurysms and Is Attenuated by Drug Therapy.
Background: Abdominal aortic aneurysms expand over time and increase the risk of fatal ruptures. To predict expansion, the isolated assessment of 18F-fluorodeoxyglucose (FDG) and sodium fluoride (NaF) uptake or calcification volume in aneurysms has been investigated with variability in results. We systematically evaluated whether 18F-FDG and 18F-NaF uptake was predictive of abdominal aortic aneurysm expansion.
Methods: Seventy-four male Sprague-Dawley rat abdominal aortic aneurysm models were imaged using positron emission tomography-computed tomography with 18F-FDG and 18F-NaF at 1, 2, 4, 6, and 8 weeks after CaCl2 or saline stimulation. In the 1-week cohort (n=25), the correlation between 18F-FDG or 18F-NaF uptake and pathological markers was investigated. In the time course cohort (n=49), animals received either atorvastatin, losartan, aldactone, or risedronate to assess the effect of these drugs, and the relationship between aortic size and sequential 18F-FDG and 18F-NaF uptake or calcification volume was examined.
Results: In the 1-week cohort, the maximum standard unit value of 18F-FDG and 18F-NaF uptake correlated with CD68- (r=0.82; P=0.001) and von Kossa staining-positive areas (r=0.89; P<0.001), respectively. In the time course cohort, 18F-FDG and 18F-NaF uptake changed in a time-dependent manner and drugs attenuated this uptake. Specifically, 18F-FDG showed high uptake at weeks 1 and 2, whereas a high 18F-NaF uptake was noted throughout the study period. Atorvastatin and risedronate showed a decreased and increased aortic size, respectively. The final aortic area correlated well with 18F-FDG and 18F-NaF uptake and calcification volume, especially at 1 and 2 weeks (18F-NaF [1 week]: r=0.61, 18F-FDG [2 weeks]: r=0.51, calcification volume [1 week]: r=0.59; P<0.001). Multiple linear regression analysis showed that the combination of these factors predicted the final aortic size, with 18F-NaF uptake at 1 week being the strongest predictor.
Conclusions: The uptake of 18F-NaF and 18F-FDG and the calcification volume at appropriate times correlated with the development of abdominal aortic aneurysms, with 18F-NaF uptake being the strongest predictor.
期刊介绍:
The journal "Arteriosclerosis, Thrombosis, and Vascular Biology" (ATVB) is a scientific publication that focuses on the fields of vascular biology, atherosclerosis, and thrombosis. It is a peer-reviewed journal that publishes original research articles, reviews, and other scholarly content related to these areas. The journal is published by the American Heart Association (AHA) and the American Stroke Association (ASA).
The journal was published bi-monthly until January 1992, after which it transitioned to a monthly publication schedule. The journal is aimed at a professional audience, including academic cardiologists, vascular biologists, physiologists, pharmacologists and hematologists.